Events and Webinars Search

Building a strong network for life science innovators
Since 1899, Daiichi Sankyo has leveraged its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular and other diseases with high unmet medical need.
Daiichi Sankyo
Focus on early-stage biotech companies
People Priorities
People Priorities
What to Know when Launching a New Company
NextGen VC Forum East Coast
NextGen VC Forum East Coast 2026
Life science VCs expanding expertise and growing networks
Beyond the Pitch
Beyond the Pitch
What First-Time Founders Don't See Coming
Investor Connect Plus
Perceptive Advisors
Reserved for BIO member companies
Investor Connect Plus
Atlas Venture
Reserved for BIO member companies
Investor Connect Plus
Luma Group
Reserved for BIO member companies

Sign up for our newsletter

Life science events, news, and insights.